EP3688012A4 - Verbindungen und verfahren zur modulation von proteinabbau - Google Patents

Verbindungen und verfahren zur modulation von proteinabbau Download PDF

Info

Publication number
EP3688012A4
EP3688012A4 EP18862294.8A EP18862294A EP3688012A4 EP 3688012 A4 EP3688012 A4 EP 3688012A4 EP 18862294 A EP18862294 A EP 18862294A EP 3688012 A4 EP3688012 A4 EP 3688012A4
Authority
EP
European Patent Office
Prior art keywords
compounds
methods
protein degradation
modulating protein
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18862294.8A
Other languages
English (en)
French (fr)
Other versions
EP3688012A1 (de
Inventor
Matthew Patricelli
Dean Stamos
Gabe SIMON
Benjamin HORNING
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vividion Therapeutics Inc
Original Assignee
Vividion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vividion Therapeutics Inc filed Critical Vividion Therapeutics Inc
Publication of EP3688012A1 publication Critical patent/EP3688012A1/de
Publication of EP3688012A4 publication Critical patent/EP3688012A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP18862294.8A 2017-09-27 2018-09-27 Verbindungen und verfahren zur modulation von proteinabbau Withdrawn EP3688012A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762564184P 2017-09-27 2017-09-27
PCT/US2018/053146 WO2019067733A1 (en) 2017-09-27 2018-09-27 COMPOUNDS AND METHODS FOR MODULATING PROTEIN DEGRADATION

Publications (2)

Publication Number Publication Date
EP3688012A1 EP3688012A1 (de) 2020-08-05
EP3688012A4 true EP3688012A4 (de) 2021-06-30

Family

ID=65902108

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18862294.8A Withdrawn EP3688012A4 (de) 2017-09-27 2018-09-27 Verbindungen und verfahren zur modulation von proteinabbau

Country Status (3)

Country Link
US (1) US20200239530A1 (de)
EP (1) EP3688012A4 (de)
WO (1) WO2019067733A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10807951B2 (en) 2017-10-13 2020-10-20 The Regents Of The University Of California mTORC1 modulators
CR20210687A (es) 2019-06-25 2022-03-03 Gilead Sciences Inc PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
US20240123078A1 (en) * 2019-10-16 2024-04-18 Vividion Therapeutics, Inc. Compounds and methods for modulating immune-related proteins
WO2021163064A2 (en) 2020-02-14 2021-08-19 Jounce Therapeutics, Inc. Antibodies and fusion proteins that bind to ccr8 and uses thereof
US20220389394A1 (en) 2021-05-18 2022-12-08 Gilead Sciences, Inc. METHODS OF USING FLT3L-Fc FUSION PROTEINS
CA3222727A1 (en) * 2021-06-17 2022-12-22 The Regents Of The University Of California E3 ligase inhibitors and methods of use thereof
CA3234909A1 (en) 2021-10-28 2023-05-04 Gilead Sciences, Inc. Pyridizin-3(2h)-one derivatives
WO2023077030A1 (en) 2021-10-29 2023-05-04 Gilead Sciences, Inc. Cd73 compounds
US20230242508A1 (en) 2021-12-22 2023-08-03 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
US20240124412A1 (en) 2021-12-22 2024-04-18 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
TW202340168A (zh) 2022-01-28 2023-10-16 美商基利科學股份有限公司 Ｐａｒｐ７抑制劑
US20230373950A1 (en) 2022-03-17 2023-11-23 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
US20230374036A1 (en) 2022-04-21 2023-11-23 Gilead Sciences, Inc. Kras g12d modulating compounds
CN114958854B (zh) * 2022-06-21 2024-05-07 宁波大学附属人民医院 Dcaf13抑制剂在制备治疗肺腺癌的药物中的应用
WO2024006929A1 (en) 2022-07-01 2024-01-04 Gilead Sciences, Inc. Cd73 compounds
CN115927664A (zh) * 2022-11-09 2023-04-07 苏州赛美科基因科技有限公司 一种用于快速鉴定irf2bpl突变系斑马鱼基因型的引物及其应用
WO2024137852A1 (en) 2022-12-22 2024-06-27 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017070611A1 (en) * 2015-10-22 2017-04-27 The Scripps Research Institute Cysteine reactive probes and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017070611A1 (en) * 2015-10-22 2017-04-27 The Scripps Research Institute Cysteine reactive probes and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ERANTHIE WEERAPANA ET AL: "Quantitative reactivity profiling predicts functional cysteines in proteomes", NATURE, vol. 468, no. 7325, 17 November 2010 (2010-11-17), London, pages 790 - 795, XP055315560, ISSN: 0028-0836, DOI: 10.1038/nature09472 *
QIAN YU ET AL: "An Isotopically Tagged Azobenzene-Based Cleavable Linker for Quantitative Proteomics", CHEMBIOCHEM, vol. 14, no. 12, 19 August 2013 (2013-08-19), pages 1410 - 1414, XP055804889, ISSN: 1439-4227, DOI: 10.1002/cbic.201300396 *
See also references of WO2019067733A1 *

Also Published As

Publication number Publication date
US20200239530A1 (en) 2020-07-30
EP3688012A1 (de) 2020-08-05
WO2019067733A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
EP3688012A4 (de) Verbindungen und verfahren zur modulation von proteinabbau
EP3661509A4 (de) Verfahren und zusammensetzungen zur modulierung der spleissung
EP3638235A4 (de) Verbindungen zur modulierung der s1p1-aktivität und verfahren zu ihrer verwendung
EP3635013A4 (de) Nectin-4-bindende proteine und verfahren zur verwendung davon
EP3270917A4 (de) Verbindungen und verfahren zum verbesserten abbau von zielproteinen
EP3322986A4 (de) Alaninbasierte modulatoren von proteolyse und assoziierte verfahren zur verwendung
EP3319944A4 (de) Mdm2-basierte modulatoren der proteolyse und zugehörige verwendungsverfahren
EP3678681A4 (de) Interleukin-18-varianten und verwendungsverfahren
EP3589319A4 (de) Glycaninteragierende verbindungen und verfahren zur verwendung
EP3218483A4 (de) Verbindungen und verfahren zur modulation von proteinen
EP3615019A4 (de) Modulatoren der sestrin-gator2-interaktion und verwendungen davon
EP3768854A4 (de) Modulatoren der hsd17b13-expression
EP3606663A4 (de) Verfahren und verwendungen von verkapselten exudaten und getrockneten euglena
EP3600716A4 (de) X-verbindungen und verfahren zur herstellung
EP3675906A4 (de) Anti-tm4sf1-antikörper und verfahren zu deren verwendung
EP3635000A4 (de) Manabodies und anwendungsverfahren
EP3728323A4 (de) Anti-frizzled-antikörper und verfahren zur verwendung
EP3444270A4 (de) Neuartiges natürliches protein und anwendung davon
EP3307297A4 (de) Verfahren und polypeptide zur modulation von immunreaktionen
EP3684819A4 (de) Anti-ykl40-antikörper und verfahren zur verwendung
EP3886853A4 (de) Diarylhydantoiverbindungen und verfahren zur verwendung davon
EP3710589A4 (de) Anti-c1s-antikörper und verfahren zur verwendung
EP3429690A4 (de) Verfahren zur modulation von keap1
EP3609867A4 (de) Carbazolverbindungen und verfahren zur verwendung davon
EP3642231A4 (de) Anti-vista-antikörper und verfahren zur verwendung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210528

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/00 20060101AFI20210521BHEP

Ipc: C07K 14/47 20060101ALI20210521BHEP

Ipc: G01N 33/542 20060101ALI20210521BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220104